These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22075527)

  • 21. Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care.
    Silverman TB; Vanegas A; Marte A; Mata J; Sin M; Ramirez JCR; Tsai WY; Crew KD; Kukafka R
    BMC Health Serv Res; 2018 Aug; 18(1):633. PubMed ID: 30103738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers.
    MacDonald DJ; Sarna L; Uman GC; Grant M; Weitzel JN
    Oncol Nurs Forum; 2006 Nov; 33(2):E27-35. PubMed ID: 16518435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying patients with a history of ovarian cancer for referral for genetic counselling: non-randomised comparison of two case-finding strategies in primary care.
    Helsper CW; Van Vliet LM; Velthuizen ME; de Wit NJ; Beijaert RP; Butter E; van Gent-Wagemakers MP; Witteveen EO; Zweemer RP; van Dulmen SM; Ausems MG
    Br J Gen Pract; 2018 Nov; 68(676):e750-e756. PubMed ID: 30348886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hereditary cancers: from discovery to intervention.
    Knudson AG
    J Natl Cancer Inst Monogr; 1995; (17):5-7. PubMed ID: 8573454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and evaluation of a colon cancer mobile application.
    Sadeghi A; Salar S; Moghadam PK; Cheraghpour M; Ghafouri R
    BMC Gastroenterol; 2024 May; 24(1):185. PubMed ID: 38807062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing colon cancer screening in primary care among African Americans.
    Myers RE; Sifri R; Daskalakis C; DiCarlo M; Geethakumari PR; Cocroft J; Minnick C; Brisbon N; Vernon SW
    J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25481829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.
    Kne A; Zierhut H; Baldinger S; Swenson KK; Mink P; Veach PM; Tsai ML
    J Genet Couns; 2017 Aug; 26(4):697-715. PubMed ID: 27826805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.
    Wilson BJ; Torrance N; Mollison J; Wordsworth S; Gray JR; Haites NE; Grant A; Campbell MK; Miedyzbrodzka Z; Clarke A; Watson MS; Douglas A
    Health Technol Assess; 2005 Feb; 9(3):iii-iv, 1-126. PubMed ID: 15694064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Permanence of the information given during oncogenetic counseling to persons at familial risk of breast/ovarian and/or colon cancer.
    Kwiatkowski F; Dessenne P; Laquet C; Petit MF; Bignon YJ
    Eur J Hum Genet; 2012 Feb; 20(2):141-7. PubMed ID: 21934710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial.
    Livaudais-Toman J; Karliner LS; Tice JA; Kerlikowske K; Gregorich S; Pérez-Stable EJ; Pasick RJ; Chen A; Quinn J; Kaplan CP
    Breast; 2015 Dec; 24(6):758-66. PubMed ID: 26476466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk-adapted starting age of breast cancer screening in women with a family history of ovarian or other cancers: A nationwide cohort study.
    Mukama T; Kharazmi E; Sundquist K; Sundquist J; Fallah M
    Cancer; 2021 Jun; 127(12):2091-2098. PubMed ID: 33620751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history.
    Nelson CL; Sellers TA; Rich SS; Potter JD; McGovern PG; Kushi LH
    Genet Epidemiol; 1993; 10(4):235-44. PubMed ID: 8224804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary breast and ovarian cancer: what the primary care physician should know.
    Khoury-Collado F; Bombard AT
    Obstet Gynecol Surv; 2004 Jul; 59(7):537-42. PubMed ID: 15199272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of women at risk of hereditary breast-ovarian cancer among participants in a population-based breast cancer screening.
    Bonelli L; Valle I; Rebora I; Ricci P; Biocchi L; Bruschi G; Parodi S; Bruzzone C; Varesco L
    Fam Cancer; 2022 Jul; 21(3):309-318. PubMed ID: 34669096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence to breast and ovarian cancer screening recommendations for female relatives from the Ontario site of the Breast Cancer Family Registry.
    Campitelli MA; Chiarelli AM; Mirea L; Stewart L; Glendon G; Ritvo P; Andrulis IL; Knight JA
    Eur J Cancer Prev; 2011 Nov; 20(6):492-500. PubMed ID: 21691207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany.
    Vetter L; Keller M; Bruckner T; Golatta M; Eismann S; Evers C; Dikow N; Sohn C; Heil J; Schott S
    Breast Cancer Res Treat; 2016 Apr; 156(2):289-99. PubMed ID: 26960712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.
    Hoskins KF; Tejeda S; Vijayasiri G; Chukwudozie IB; Remo MH; Shah HA; Abraham IE; Balay LE; Maga TK; Searles ER; Korah VJ; Biggers A; Stolley MR; Warnecke RB
    Cancer; 2018 Sep; 124(18):3733-3741. PubMed ID: 30320429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: a statewide initiative.
    Brannon Traxler L; Martin ML; Kerber AS; Bellcross CA; Crane BE; Green V; Matthews R; Paris NM; Gabram SG
    Ann Surg Oncol; 2014 Oct; 21(10):3342-7. PubMed ID: 25047474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population-based Genetic Testing for Precision Prevention.
    Evans O; Manchanda R
    Cancer Prev Res (Phila); 2020 Aug; 13(8):643-648. PubMed ID: 32409595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.
    Kukafka R; Pan S; Silverman T; Zhang T; Chung WK; Terry MB; Fleck E; Younge RG; Trivedi MS; McGuinness JE; He T; Dimond J; Crew KD
    JAMA Netw Open; 2022 Jul; 5(7):e2222092. PubMed ID: 35849397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.